CBD Legal in France 2026: What to Know Before You Buy

Cannabidiol (CBD) is one of the cannabinoids found in the Cannabis sativa plant. Unlike THC, CBD is not classified as a psychotropic substance by French and European authorities, provided the THC content remains below the legal threshold.

THC is the molecule responsible for the psychoactive effects of cannabis. This distinction determines the legality of a product. A legal CBD product does not produce an intoxicating effect and does not contain THC above the permitted threshold.

CBD and THC coexist naturally in the plant. Selective breeding and processing make it possible to obtain products with a high CBD content and a very low THC level.

• CBD: non-psychotropic, regulated legally
• THC: psychoactive, prohibited above the legal threshold
• The CBD/THC distinction is at the heart of the regulatory framework
• A single product can contain both in different proportions

Under current regulations, the legal THC limit in France is set at 0.3% in the finished product. This threshold applies to virtually all CBD products: flowers, resins, oils, cosmetics, and supplements.

This level is aligned with European regulations adopted since 2021. Previously, France applied 0.2% to harvestable parts. The move to 0.3% represents a convergence with EU standards.

To ensure compliance, the most reliable reference remains a seller operating within a direct and traceable supply chain, one who clearly displays the THC level and knows the origin of their products. An analysis certificate can serve as further confirmation.

• Legal THC threshold since 2021: 0.3% in the finished product
• Previous rule was 0.2%, now raised to 0.3%
• Direct supply chain and clearly displayed THC level: the trust benchmarks
• A level above 0.3% makes the product illegal in France

The sale of CBD flowers and resins has long been a source of legal tension. After several reversals and court decisions, the sale of flowers is now tolerated under strict conditions linked to the THC level and presentation requirements.

In 2022, the Council of State suspended a decree banning the sale of flowers. Since then, flowers that comply with the THC threshold can be sold commercially, although the situation continues to evolve. Consult official texts for any specific questions.

Resins (CBD hash) operate under a similar framework, subject to THC compliance and full traceability. Serious operators work within a direct supply chain and are able to document the origin of every reference they carry.

• CBD flowers: commercially available if THC is below 0.3%
• The Council of State validated their sale under specific conditions
• CBD resins: same framework, traceability required
• Evolving regulations: check for updates regularly
• Restricted to adults aged 18 and over

CBD oils intended for oral consumption have been subject to the European Novel Food regulation, managed by the EFSA, since 2022: any food product based on CBD must receive authorisation before being placed on the market.

In practice, ingestible CBD extracts must obtain Novel Food authorisation to be marketed as food products in the EU. As of 2026, the process is still ongoing for several applications.

This development has affected the product landscape: some items have been withdrawn or reformulated. Oils intended for external use (cosmetic) are not affected. It is important to distinguish between topical and ingestible use.

• Ingestible oils: subject to Novel Food (EU)
• EFSA authorisation required for food use
• In 2026, several applications still under review
• Cosmetic oils (external use): not affected
• Check the status of each product before purchasing

In 2026, CBD is not classified as a narcotic in France provided the product respects the THC threshold. However, several aspects remain strictly regulated.

Advertising for CBD products is regulated: any medical or therapeutic claim is expressly prohibited. A seller cannot state that CBD treats, cures, or prevents any illness. Communications remain informational, without health claims.

Sales are restricted to adults (18 and over). Certain uses remain prohibited, such as consumption while driving, and roadside drug tests do not distinguish between CBD and THC. Refer to official texts for any up-to-date information.

• CBD legal if THC is below 0.3% in the finished product
• Medical or therapeutic claims: prohibited
• Sales restricted to adults aged 18 and over
• Roadside testing: does not distinguish CBD from THC, caution advised when driving
• Official sources: Journal Officiel, MILDECA